CDC20 promotes bone formation via APC/C dependent ubiquitination and degradation of p65

© 2021 The Authors. Published under the terms of the CC BY 4.0 license..

The E3 ubiquitin ligase complex CDC20-activated anaphase-promoting complex/Cyclosome (APC/CCDC20 ) plays a critical role in governing mitotic progression by targeting key cell cycle regulators for degradation. Cell division cycle protein 20 homolog (CDC20), the co-activator of APC/C, is required for full ubiquitin ligase activity. In addition to its well-known cell cycle-related functions, we demonstrate that CDC20 plays an essential role in osteogenic commitment of bone marrow mesenchymal stromal/stem cells (BMSCs). Cdc20 conditional knockout mice exhibit decreased bone formation and impaired bone regeneration after injury. Mechanistically, we discovered a functional interaction between the WD40 domain of CDC20 and the DNA-binding domain of p65. Moreover, CDC20 promotes the ubiquitination and degradation of p65 in an APC11-dependent manner. More importantly, knockdown of p65 rescues the bone loss in Cdc20 conditional knockout mice. Our current work reveals a cell cycle-independent function of CDC20, establishes APC11CDC20 as a pivotal regulator for bone formation by governing the ubiquitination and degradation of p65, and may pave the way for treatment of bone-related diseases.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:22

Enthalten in:

EMBO reports - 22(2021), 9 vom: 06. Sept., Seite e52576

Sprache:

Englisch

Beteiligte Personen:

Du, Yangge [VerfasserIn]
Zhang, Min [VerfasserIn]
Liu, Xuejiao [VerfasserIn]
Li, Zheng [VerfasserIn]
Hu, Menglong [VerfasserIn]
Tian, Yueming [VerfasserIn]
Lv, Longwei [VerfasserIn]
Zhang, Xiao [VerfasserIn]
Liu, Yunsong [VerfasserIn]
Zhang, Ping [VerfasserIn]
Zhou, Yongsheng [VerfasserIn]

Links:

Volltext

Themen:

APC/C
Anaphase-Promoting Complex-Cyclosome
BMSCs
CDC20
Cdc20 Proteins
Cdc20 protein, mouse
Cell Cycle Proteins
EC 2.3.2.27
Journal Article
Osteogenic differentiation
P65
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 22.10.2021

Date Revised 31.05.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.15252/embr.202152576

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM329266063